Stada Group
Dr. Anna Wilcken has a work experience starting in 2013 at Freshfields Bruckhaus Deringer, where they worked as a Rechtsanwältin until June 2015. In 2015, they joined STADA Group as a Senior Legal Counsel and later became the Director of Legal Affairs Corporate Governance in October 2016.
Dr. Anna Wilcken attended Universität Passau where they studied Jura. No information regarding the start and end years of their education is provided.
This person is not in any teams
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.